The salt check sheet developed by Tsuchihashi et al. is widely used in general practice to assess salt intake and the associated diets. However, its appropriateness for the general population has not been assessed alongside 24-h urinary salt excretion monitoring. Therefore, in local residents, we analyzed the correlation between check-sheet scores and 24-h urinary salt excretion levels to determine the appropriateness of the check sheet. We asked 176 local residents to complete the salt check sheet and provide urinary samples; the latter were obtained using a proportional sampling method over a 24-h period. One hundred and forty subjects completed the study (men/women: 23/117, mean±s.d. age: 52.7±19.6 years, blood pressure: 122.3±18.0/74.3±11.1 mm Hg), of whom 51 (36.4%) had hypertension. The total salt check-sheet scores were widely distributed (mean±s.d.: 11.1±4.2 points, range: 0-22 points), and the subjects were divided into the following groups on the basis of salt levels: 29.3% were 'low' (0-8 points), 42.8% were 'medium' (9-13 points), 23.6% were 'high' (14-19 points) and 4.3% were 'very high' (>20 points). The mean 24-h urinary salt excretion level was 8.5±3.3 g. The subjects with higher salt-intake levels tended to have increased 24-h urinary salt excretion levels, with significant differences between the three groups ('low' vs. 'medium' vs. 'high to very high' salt levels: 7.6±2.9 g vs. 8.4±2.8 g vs. 9.6±4.2 g, respectively; P=0.03). The total salt check-sheet scores significantly correlated with the 24-h urinary salt excretion levels (r=0.27; P<0.01). Thus, the salt check sheet is applicable for the general population.
Self-measured salt excretion from overnight urine samples shows significant correlation with 24-h-urinary salt excretion, but it is not known whether a self-measuring method can monitor daily fluctuations in individual salt consumption. In this study, we measured salt excretion from 24-h urine samples (24-h salt) in 50 volunteers over 3 test days (2 weekdays and 1 holiday), and examined to what extent the values correlated with estimates of 24-h salt excretion from overnight urine samples obtained using a self-monitoring device (ON salt). Urine collection was considered successful when the difference between the predicted and actual 24-h-urinary creatinine excretion was within 30%. Thirty-three (M/F=7/26; 39.6±16.7 years) out of 50 participants completed their urine collections successfully and their samples were used in the analysis. Twenty-four-hour salt and ON salt did not significantly differ between test days and between the weekdays and the holiday. Moreover, there was a significant positive correlation between 24-h salt and ON salt for each test day. The coefficients of variation (CVs) for 24-h salt among test days and among subjects were 24.7% and 21.3%, respectively. The CVs for ON salt were lower than those for 24-h salt (13.3% and 17.7%, respectively). In conclusion, self-measurement of salt excretion from overnight urine samples allows estimation of daily salt intake; thus, the use of a self-monitoring device may be a useful motivational tool for personal salt restriction.
Abstract. Body cell mass (BCM) is a nutritional parameter, however, changes in BCM in patients with non-ascitic liver cirrhosis (LC) in comparison to patients with other malnutritional diseases remains unclear. We investigated the difference in BCM between patients with LC and malnourished gastrointestinal disease controls (M.CON), and examined the relationship between BCM and the severity of LC. Results demonstrated that serum nutritional parameters were not significantly different between the LC (n=56) and M.CON groups (n=25), whereas BCM%BW was significantly lower in the LC group than in the M.CON group (50.9±4.6 vs. 54.4±7.1%, P=0.018). Furthermore, BCM%BW negatively correlated with the model for end-stage liver disease (MELD) score (P=0.04). In concluson, BCM showed a significant decrease and a negative correlation with the MELD score in the LC group. BCM may be a useful parameter for assessing malnutrition and severity of
Objective There is little long-term data on the association between the serum albumin levels and mortality in community-based populations. We aimed to determine whether the serum albumin level is an independent risk factor for all-cause and cause-specific death in a community-based cohort study in Japan. Methods In 1999, we performed a periodic epidemiological survey over a 15-year period in a population of 1,905 healthy subjects (783 males, 1,122 females) who were older than 40 years of age and who resided in Tanushimaru, a rural community, in Japan. Over the course of the study, we periodically examined the blood chemistry of the study subjects, including their serum albumin levels. Their baseline serum albumin levels were categorized into quartiles. Results The baseline albumin levels were significantly associated with age (inversely), body mass index (BMI), diastolic blood pressure, lipid profiles [high density lipoprotein-cholesterol (HDL-c), low-density lipoprotein-cholesterol (LDL-c) and triglycerides] and estimated glomerular filtration rate (eGFR). After adjusting for confounders, a Cox proportional hazards regression analysis demonstrated that a low serum albumin level was an independent predictor of all-cause death [hazard ratio (HR): 0.39, 95% confidence interval (CI): 0.24-0.65], cancer death (HR: 0.43, 95% CI: 0.18-0.99), death from infection (HR: 0.21, 95% CI: 0.06-0.73) and cerebro-cardiovascular death (HR: 0.19, 95% CI: 0.06-0.63). The HRs for all-cause and cerebro-cardiovascular death in the highest quartile vs. the lowest quartile of albumin after adjusting for confounders were 0.59 (95%CI:0.39-0.88) and 0.15 (95%CI: 0.03-0.66), respectively. Conclusion The serum albumin level was thus found to be a predictor of all-cause and cerebro-cardiovascular death in a general population.
To prevent and treat hypertension, it is important to restrict salt in one's diet since adolescence. However, an effective salt‐reduction education system has yet to be established. Besides accurate evaluation, we believe that the frequent usage of a measurement device may motivate individuals to avoid high salt intake. The present study evaluated the use of a urinary salt excretion measurement device for salt‐reduction education in a parallel randomized trial of two groups. The sample comprised 100 university students who provided consent to participate. A survey with 24‐hour home urine collection and blood pressure measurement was conducted. Participants in the self‐monitoring group measured their own urinary salt excretion level for 4 weeks, using the self‐measurement device. Analyses were conducted on 51 participants in the control group and 49 in the self‐monitoring group. At baseline, there was no significant difference between the two groups in terms of their characteristics and 24‐hour urinary salt excretion levels. After intervention, 24‐hour urinary sodium/potassium ratio showed no change in the control group [baseline score: 4.1 ± 1.5; endline score: 4.2 ± 2.0; P = 0.723], but it decreased significantly in the self‐monitoring group [baseline score: 4.0 ± 1.7; endline score: 3.5 ± 1.4; P = 0.044]. This change was significant even after adjusting for baseline and endline differences between groups using analysis of covariance (P = 0.045). The self‐monitoring urinary salt excretion measurement device improved the 24‐hour urinary sodium/potassium ratio. The device is a useful and practical tool for educating young individuals about dietary salt reduction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.